Virios Therapeutics (NASDAQ:VIRI) Trading 0.7% Higher – Here’s What Happened

Virios Therapeutics, Inc. (NASDAQ:VIRI)’s stock price shot up 0.7% during trading on Monday . The company traded as high as $1.4272 and last traded at $1.38. Approximately 73,869 shares traded hands during mid-day trading, a decline of 93% from the average session volume of 1,049,645 shares. The stock had previously closed at $1.37.

Virios Therapeutics Trading Up 0.7%

The stock’s fifty day moving average price is $1.59 and its two-hundred day moving average price is $2.28. The firm has a market capitalization of $26.58 million, a price-to-earnings ratio of -5.11 and a beta of 1.58.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.

The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.